Verona Pharma(VRNA) - 2024 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 7, 2025 Verona Pharma plc (Exact name of registrant as specified in its charter) United Kingdom 001-38067 98-1489389 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 3 More London Riverside London SE1 2RE United Kingdom (Address o ...